Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Coivas review
Flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay.
then $149/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Coivas at a glance
- Semaglutide
- $149/mo after the intro period
- Tirzepatide
- $229/mo after the intro period
- Coverage
- All 50 states
- Start
- Not published
How we scored Coivas
Each factor is read off Coivas's published pricing, disclosures and intake flow, and the six roll up into the 69/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair pricing once you read past any teaser or plan structure.
All 50 states — a move for work or family won't interrupt care.
Both molecules, though pricing on one isn't cleanly posted.
Cancellation is workable but not frictionless.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
The weakest showing on speed — a slow published timeline, or none at all.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- coivas.com
Prices come from Coivas's own cards and comparison chart, checked in August 2026. Both numbers are published: $119 then $149 for semaglutide, $199 then $229 for tirzepatide, flat at every dose. The site notes that dosage and titration can affect the price, so treat them as starting points.
What to expect when you sign up
We walked Coivas's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves coivas.com for intake.coivas.com, a separate host
- 2The signup page opened normally when we checked it on 2026-08-21
- 3We stopped at the first signup screen and entered no personal details, so we can't tell you what comes after it
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
- Intake is hosted on intake.coivas.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideAll doses (flat)"From $119 · Monthly" to start; $149 flat after the introductory period. | $119 → $149 | All doses (flat)"From $119 · Monthly" to start; $149 flat after the introductory period. |
| Compounded tirzepatideAll doses (flat)"From $199 · Monthly" to start; $229 flat thereafter. | $199 → $229 | All doses (flat)"From $199 · Monthly" to start; $229 flat thereafter. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Coivas's public disclosures at last review and change often; confirm the current number on Coivas's own site.
What we like
- Flat at every dose — the bill does not climb as you titrate
- Both the intro and the ongoing price are published on the same page
- All 50 states
- Consultation, prescription, medication, shipping and support are included in the one price
- Cancel any time, per its subscription terms
The caveats
- $119 and $199 are introductory; the ongoing rates are $149 and $229
- Prices are prefixed "from" and the site says dosage and titration can change them
- Compounded only — no FDA-approved brand option
- No oral or sublingual form
- Labs are not mentioned anywhere on the site
Coivas for working moms: our verdict
Flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay. The advertised entry is $119, but the standing rate settles near $149/month — so read the headline as a starting offer, not the monthly line on your budget.
We weigh Coivas the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Coivas will cost you
- Compounded semaglutide — All doses (flat): $119 to start, then $149/mo
- Compounded tirzepatide — All doses (flat): $199 to start, then $229/mo
That sits below the roughly $179 median ongoing price across the providers we track for working moms — a real cost advantage.
The medications Coivas prescribes
Coivas prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Coivas fits — and where it doesn't — for working moms
Right for you if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
- you want a flat price that doesn't climb every time you titrate up a dose.
- nationwide access matters — a move for work or family shouldn't interrupt care.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Coivas is a genuine value play — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Anyone who needs one predictable monthly number to plan around and does not need brand-name Wegovy or an oral option.
Alternatives to Coivas
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Coivas
Head-to-head & alternatives
Coivas, answered
- How much does Coivas cost?
- Budget around $149 a month — that was Coivas's lowest ongoing compounded rate at last review ($149/mo after the intro period semaglutide, $229/mo after the intro period tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Coivas without a scheduled video visit?
- Coivas involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Coivas offer both semaglutide and tirzepatide?
- Yes — Coivas offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Coivas rank for working moms?
- Coivas earns 69/100 on our Rx-Readiness Score, ranking #41. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect Coivas's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.